HomeInsightsMarket Capitalization

Market Capitalization of Natco Pharma Ltd

Market Capitalization of Natco Pharma Ltd

stocks purchased

₹ 2.9 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

19.8 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 15, 2024

Image

Natco Pharma Ltd

NSE: NATCOPHARM

Market Cap

₹ 25823.17 crore

Last updated on: Dec 13, 2024

Key Highlights

  • The Market Cap of Natco Pharma Ltd is ₹ 25823 crore as of 13 Dec 24 .
  • The Market Cap of Natco Pharma Ltd changed from ₹ 10515 crore on March 2019 to ₹ 17042 crore on March 2024 . This represents a CAGR of 8.38% over 6 years.
  • The Latest Trading Price of Natco Pharma Ltd is ₹ 1441 as of 13 Dec 15:30 .
  • The Dividend Payouts of Natco Pharma Ltd changed from ₹ 1.25 on Feb 21, 2023 to ₹ 1.5 on Nov 27, 2024 . This represents a CAGR of 3.09% over 6 years.

Historical Market Cap of Natco Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Natco Pharma Ltd

No data available

Image

Natco Pharma Ltd

NSE: NATCOPHARM

Share Price

₹ 1441.75

-28.45 (-1.94%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 20241441.75
12 Dec 20241470.2
11 Dec 20241463.45
10 Dec 20241491.25
09 Dec 20241485.45
06 Dec 20241450.6
05 Dec 20241441.05
04 Dec 20241430.75
03 Dec 20241429.5
02 Dec 20241414.8

SWOT Analysis Of Natco Pharma Ltd

Strength

4

S

Weakness

3

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Natco Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Natco Pharma Ltd

No data available

No data available

Historical P/E Ratio of Natco Pharma Ltd

No data available

* All values are in %

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Natco Pharma Ltd

No data available

* All values are in

About Natco Pharma Ltd

  • Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.
  • It sells products in over 40 countries.
  • FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
  • Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.

Natco Pharma Ltd News Hub

News

Natco Pharma Ltd soars 1.05%, Gains for third straight session

Natco Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 1...

Read more

03 Dec 2024 13:06

News

Natco Pharma sells Telangana land for Rs 116 crore

The drug maker stated that since no business operations are carried out on the said land a...

Read more

28 Nov 2024 11:31

News

Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution

Natco Pharma today announced submission of Abbreviated New Drug Application (ANDA) with US...

Read more

21 Nov 2024 17:35

News

Natco Pharma submits ANDA with US FDA for Risdiplam

The ANDA is a generic version of Evrysdi (Risdiplam) for oral solution by Genentech Inc. R...

Read more

21 Nov 2024 15:00

News

Natco Pharma Ltd eases for fifth straight session

Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 13...

Read more

13 Nov 2024 13:14

News

Board of Natco Pharma recommends second interim dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 1...

Read more

12 Nov 2024 17:01

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Natco Pharma Ltd Market Cap

What is the market cap of Natco Pharma Ltd?

As of December 15, 2024, Natco Pharma Ltd has a market capitalization of ₹25823.17, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Natco Pharma Ltd's market capitalization?

Natco Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Natco Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Natco Pharma Ltd's market capitalization change?

Natco Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions